Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status

MLA

Kenichi Nomoto, et al. “Sensitivity to the MEK Inhibitor E6201 in Melanoma Cells Is Associated with Mutant BRAF and Wildtype PTEN Status.” Molecular Cancer, vol. 11, Oct. 2012. EBSCOhost, https://doi.org/10.1186/1476-4598-11-75.

APA

Kenichi Nomoto, Sara A. Byron, John Wang, Candice L. Wellens, Jiayi Wu, Andreas Wortmann, David Loch, & Pamela M. Pollock. (2012). Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status. Molecular Cancer, 11. https://doi.org/10.1186/1476-4598-11-75

Chicago

Kenichi Nomoto, Sara A. Byron, John Wang, Candice L. Wellens, Jiayi Wu, Andreas Wortmann, David Loch, and Pamela M. Pollock. 2012. “Sensitivity to the MEK Inhibitor E6201 in Melanoma Cells Is Associated with Mutant BRAF and Wildtype PTEN Status.” Molecular Cancer 11 (October). doi:10.1186/1476-4598-11-75.